Collegium Pharmaceutical Inc
COLL30.195USD
+0.125+0.42%
交易中 （美东）报价延迟15分钟
970.22M总市值
22.10市盈率 TTM
关于 Collegium Pharmaceutical Inc 公司
Collegium Pharmaceutical, Inc. 是一家多元化的专业制药公司。该公司在美国销售其止痛药产品组合，包括 Xtampza 缓释 (ER)、Nucynta ER 和 Nucynta 速释 (IR)、Belbuca 和 Symproic。Xtampza ER 是一种抗滥用缓释口服羟可酮制剂。Xtampza ER 是一种具有抗滥用特性的止痛药治疗方案，使用技术平台 DETERx。Nucynta 产品是他喷他多的 ER 和 IR 口服制剂。Nucynta ER 用于治疗需要长期每日服用阿片类止痛药治疗的严重和持续性疼痛。Nucynta IR 用于治疗严重到需要服用阿片类止痛药的急性疼痛。Belbuca 是一种含丁丙诺啡的颊膜，用于治疗严重和持续性疼痛。 Symproic 用于治疗成人患者阿片类药物引起的便秘 (OIC)。其产品组合还包括 Jornay PM。
公司简介
公司代码COLL
公司名称Collegium Pharmaceutical Inc
上市日期May 07, 2015
CEOMr. Vikram Karnani
员工数量357
证券类型Ordinary Share
年结日May 07
公司地址100 Technology Center Dr
城市STOUGHTON
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编02072-4710
电话17817133699
网址https://www.collegiumpharma.com/
公司代码COLL
上市日期May 07, 2015
CEOMr. Vikram Karnani
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Vikram Karnani
Mr. Vikram Karnani
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.97K
--
Mr. David Dieter
Mr. David Dieter
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
68.45K
--
Ms. Colleen Tupper
Ms. Colleen Tupper
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
42.18K
-37.97%
Mr. Gino Santini
Mr. Gino Santini
Independent Chairman of the Board
Independent Chairman of the Board
35.23K
+38.49%
Dr. Rita J. Balice-Gordon, Ph.D.
Dr. Rita J. Balice-Gordon, Ph.D.
Independent Director
Independent Director
33.77K
+40.84%
Ms. Nancy S. Lurker
Ms. Nancy S. Lurker
Independent Director
Independent Director
22.52K
+76.94%
Dr. Carlos V. Paya, M.D., Ph.D.
Dr. Carlos V. Paya, M.D., Ph.D.
Independent Director
Independent Director
19.58K
--
Mr. Garen G. Bohlin
Mr. Garen G. Bohlin
Independent Director
Independent Director
--
--
Dr. John A. Fallon, M.D.
Dr. John A. Fallon, M.D.
Independent Director
Independent Director
--
--
Ms. Jane Gonnerman
Ms. Jane Gonnerman
Executive Vice President - Strategy and Corporate Development
Executive Vice President - Strategy and Corporate Development
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Vikram Karnani
Mr. Vikram Karnani
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
105.97K
--
Mr. David Dieter
Mr. David Dieter
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
68.45K
--
Ms. Colleen Tupper
Ms. Colleen Tupper
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
42.18K
-37.97%
Mr. Gino Santini
Mr. Gino Santini
Independent Chairman of the Board
Independent Chairman of the Board
35.23K
+38.49%
Dr. Rita J. Balice-Gordon, Ph.D.
Dr. Rita J. Balice-Gordon, Ph.D.
Independent Director
Independent Director
33.77K
+40.84%
Ms. Nancy S. Lurker
Ms. Nancy S. Lurker
Independent Director
Independent Director
22.52K
+76.94%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Nucynta IR
75.06M
42.23%
Xtampza ER
51.66M
29.06%
Jomay PM
28.54M
16.06%
Belbuca
27.42M
15.42%
Nucynta ER
19.69M
11.07%
Symproic
2.81M
1.58%
暂无数据
业务
地区
业务USD
名称
营收
占比
Nucynta IR
75.06M
42.23%
Xtampza ER
51.66M
29.06%
Jomay PM
28.54M
16.06%
Belbuca
27.42M
15.42%
Nucynta ER
19.69M
11.07%
Symproic
2.81M
1.58%
股东统计
更新时间: 5月17日 周六
更新时间: 5月17日 周六
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
15.05%
Rubric Capital Management LP
9.33%
Eventide Asset Management, LLC
8.21%
The Vanguard Group, Inc.
6.97%
Renaissance Technologies LLC
5.03%
Other
55.41%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
15.05%
Rubric Capital Management LP
9.33%
Eventide Asset Management, LLC
8.21%
The Vanguard Group, Inc.
6.97%
Renaissance Technologies LLC
5.03%
Other
55.41%
股东类型
持股股东
占比
Investment Advisor
59.13%
Investment Advisor/Hedge Fund
31.78%
Hedge Fund
20.75%
Research Firm
3.18%
Individual Investor
1.79%
Pension Fund
1.21%
Bank and Trust
0.45%
Sovereign Wealth Fund
0.41%
Venture Capital
0.07%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
511
38.19M
118.82%
-4.98M
2025Q1
528
38.32M
119.23%
-5.70M
2024Q4
520
38.61M
122.59%
-6.60M
2024Q3
498
39.90M
123.83%
-6.67M
2024Q2
486
41.00M
125.33%
-4.08M
2024Q1
464
41.14M
125.78%
-3.32M
2023Q4
434
40.31M
123.54%
-3.32M
2023Q3
425
39.87M
114.82%
-4.18M
2023Q2
428
40.45M
116.96%
-4.39M
2023Q1
425
40.62M
117.50%
-1.29M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
4.84M
15.05%
-111.68K
-2.26%
Mar 31, 2025
Rubric Capital Management LP
3.00M
9.33%
+650.00K
+27.66%
Mar 31, 2025
Eventide Asset Management, LLC
2.64M
8.21%
+845.00
+0.03%
Mar 31, 2025
The Vanguard Group, Inc.
2.24M
6.97%
-36.10K
-1.59%
Mar 31, 2025
Renaissance Technologies LLC
1.62M
5.03%
-45.50K
-2.74%
Mar 31, 2025
Principal Global Investors (Equity)
1.57M
4.89%
-71.69K
-4.36%
Mar 31, 2025
Emerald Advisers LLC
1.40M
4.36%
+19.31K
+1.40%
Mar 31, 2025
State Street Global Advisors (US)
1.38M
4.28%
-62.15K
-4.32%
Mar 31, 2025
Fuller & Thaler Asset Management Inc.
1.37M
4.27%
+19.57K
+1.45%
Mar 31, 2025
Invesco Advisers, Inc.
953.91K
2.97%
-27.98K
-2.85%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco Pharmaceuticals ETF
2.71%
Invesco Biotechnology & Genome ETF
2.67%
SPDR S&P Pharmaceuticals ETF
1.53%
Ballast Small/Mid Cap ETF
1.34%
ETC 6 Meridian Small Cap Equity ETF
1.16%
Invesco S&P SmallCap 600 GARP ETF
1.13%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.09%
VictoryShares Small Cap Free Cash Flow ETF
0.83%
Invesco S&P SmallCap 600 Pure Growth ETF
0.71%
Invesco S&P SmallCap Health Care ETF
0.68%
查看更多
Invesco Pharmaceuticals ETF
占比2.71%
Invesco Biotechnology & Genome ETF
占比2.67%
SPDR S&P Pharmaceuticals ETF
占比1.53%
Ballast Small/Mid Cap ETF
占比1.34%
ETC 6 Meridian Small Cap Equity ETF
占比1.16%
Invesco S&P SmallCap 600 GARP ETF
占比1.13%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
占比1.09%
VictoryShares Small Cap Free Cash Flow ETF
占比0.83%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.71%
Invesco S&P SmallCap Health Care ETF
占比0.68%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
